美国食品和药物管理局批准了第四边境公司的新型可穿戴心电图监测器, Fourth Frontier's new wearable ECG monitor gains FDA approval, aiming to detect heart issues in active users.

Fourth Frontier 的 Frontier X Plus 是一款可穿戴式单导联心电图监护仪，已获得 FDA 的批准。 Fourth Frontier's Frontier X Plus, a wearable single-lead ECG monitor, has received FDA clearance. 该装置无线发送实时心脏数据,并可以对节奏进行分类,如Atravial Fibrilation,显示信号质量与12个领先的ECG相仿。 The device wirelessly sends real-time heart data and can classify rhythms like Atrial Fibrillation, showing signal quality comparable to 12-lead ECGs. 为了及早发现,特别是针对活跃的个人,它将作为处方装置出售,与诊断和康复中心合作。 Aimed at early detection, especially for active individuals, it will be sold as a prescription device, partnering with diagnostic and rehabilitation centers. 该公司还计划采用人工智能进行先进的心脏状况分析。 The company also plans to integrate AI for advanced heart condition analysis.